Case File
efta-efta00705180DOJ Data Set 9OtherFrom: "Barrett, Paul S"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00705180
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Barrett, Paul S"
To: "'Jeffrey Epstein"' <jeevacation®gmail.com>
Subject: RE: To Do: BRL step-up note - closing today
Date: Tue, 12 Mar 2013 16:35:33 +0000
Hi Jeffrey
Left you a vm.
I do think we should put some money into this note. Being long brl Into the World Cup makes sense. Domestic
inflation should allow them to allow minor fx appreciation. And they will likely hike 150bps this year. We don't
have much Latam fx exposure. Our MXN is working well.
I think we should do 1mm in southern trust.
Paul
Sent with Good (www.good.com)
Original Message
From: Ens, Amanda
Sent: Tuesday, March 12, 2013 09:39 AM Eastern Standard Time
To: Jeffrey Epstein
Cc: Barrett, Paul S
Subject: To Do: BRL step-up note - closing today
Jeffrey,
With the Brazilian policy rate at 7.25% and rate hikes increasingly likely in an effort to stem inflation, we remain
structurally bullish on the Brazilian real due to the attractive carry.
Paul recommends you invest $2mm in this BRL currency note.
HSBC-issued BRL Step-up Note
Tenor: 53 weeks
At expiry barrier protection: 15%
ATMS strike coupon: 5%
Step-Up strike: 3% OTMS
Step-up coupon: 23.5%
Max gain: 28.5%
•
If BRL performance is between -15% and 0%, you receive your principal back
•
If BRL performance is between 0% and 3%, +5% return
•
If BRL is 3% stronger at expiry, +28.5% return
•
If BRL performance is weaker than -15%, 1-for-1 loss from initial spot
More drivers of our constructive BRL view:
EFTA00705180
Brazil continues to have an inflationary problem, with y/y inflation above 6% and still rising. Even though many analysts
expect inflationary pressure to recede as the year progresses (JPM IB expects y/y inflation to fall to 5.6% by year end), the
stickiness of inflation has raised expectations that a tightening cycle is coming. Consequently, it was the comments
accompanying the decision to keep rates unchanged at 7.25% that mattered for markets last week. The statement duly
delivered. The reference to maintaining rates constant for a prolonged period of time was dropped and the committee
stated it will monitor the macro outlook to decide its next steps. However, as more hawkish language was expected by
many (as indeed are rate hikes), the confirmation afforded the BRL moderate support. It took the upside surprise on CPI
inflation on Friday to push USDBRL briefly through 1.95— close to the level where the Central Bank recently intervened in
the derivatives market. With momentum in the BRL continuing to build, further near term tests of this level seems likely.
Longer term, the performance of the BRL is likely to depend on how much the economy strengthens. After all, the
authority's concerns that loose monetary policy elsewhere had caused the BRL to decouple from its fundamentals was a
key reason for their intervention last year. But, one consequence of a weaker currency is inflation — which they now have
to deal with. Consequently, even in a bearish scenario, where inflation comes off and growth fails to materialise, we think
it is highly unlikely that the authorities would act to push the BRL to the very weak levels seen last year.
Thanks,
Amanda
Amanda Ens I Vice President I Global Investment Opportunities I J.P.Morgan I NMLS ID:
320 Park Ave, 14th Floor, New York, NY 10022
F:
I M
NOT AN OFFICIAL CONFIRMATION
For informational purposes only. This report does not represent an official account of the holdings, balances, or transactions made in
your account and is being provided at your request. Please refer to your monthly account statement for the official record of all of
your account activities. For question, please call your J.P. Morgan representative.
This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities,
accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity disclaimers, available at
SI
://www.jpmorgan.com/pages/disclosures/email.
IRS Circular 230 Disclosure: JPMorgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax
matters contained herein (including any attachments) is not intended or written to be used, and cannot be used, in connection with
the promotion, marketing or recommendation by anyone unaffiliated with JPMorgan Chase & Co. of any of the matters addressed
herein or for the purpose of avoiding U.S. tax-related penalties.
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://wwwjpmorgan.com/pages/disclosures/email.
EFTA00705181
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
gmail.comDomain
www.good.comDomain
www.jpmorgan.comSWIFT/BIC
OFFICIALURL
http://wwwjpmorgan.com/pages/disclosures/emailWire Ref
referenceRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.